Journal of Cancer Research and Therapeutics Close
 

Figure 4: RANKL/OPG ratio in patients with ADC. RANKL/OPG ratio was calculated using serum RANKL levels/serum OPG levels. *P < 0.05, ***P < 0.001. RANKL = Receptor activator of nuclear factor kappa-B ligand, OPG = Osteoprotegerin, Control = Healthy individuals, ADC = Lung adenocarcinoma, BM = Bone metastasis, Chemo = Chemotherapy

Figure 4: RANKL/OPG ratio in patients with ADC. RANKL/OPG ratio was calculated using serum RANKL levels/serum OPG levels. *<i>P</i> < 0.05, ***<i>P</i> < 0.001. RANKL = Receptor activator of nuclear factor kappa-B ligand, OPG = Osteoprotegerin, Control = Healthy individuals, ADC = Lung adenocarcinoma, BM = Bone metastasis, Chemo = Chemotherapy